Gerresheimer AG (GXI.F)
| Previous Close | 101.80 |
| Open | 101.80 |
| Bid | 101.80 x 33200 |
| Ask | 102.20 x 33200 |
| Day's Range | 101.80 - 101.80 |
| 52 Week Range | 83.05 - 122.80 |
| Volume | |
| Avg. Volume | 181 |
| Market Cap | 3.523B |
| Beta (5Y Monthly) | 0.90 |
| PE Ratio (TTM) | 29.25 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.25 (1.23%) |
| Ex-Dividend Date | Jun 06, 2024 |
| 1y Target Est | N/A |
- PR Newswire
Gerresheimer awarded EcoVadis Gold status again
Gerresheimer, an innovative provider of systems and solutions and a global partner for the pharma, biotech, and cosmetic industries, has once again been awarded Gold status by the ratings agency EcoVadis. EcoVadis assesses the performance of businesses on environmental, labor and human rights, ethical, and sustainable procurement criteria. More than 100,000 companies worldwide turn to EcoVadis for CSR performance reviews. Gerresheimer earned a spot in the top 5% of all companies assessed by EcoV
- ACCESSWIRE
Gerresheimer AG: Gerresheimer Continues Dynamic Growth in First Half of 2023
Gerresheimer, an innovative provider of systems and solutions and a global partner for the pharma and biotech industries, has continued its profitable growth, posting strong results for the first half of the year. Revenues grew organically, without foreign exchange rate effects, by 16.6% to reach EUR 957.4m. Adjusted EBITDA was EUR 185.2m.
